Deferred Income Tax - Xeris Biopharma Holdings Inc (NASDAQ:XERS) - Alpha Spread

Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 2.965 USD -0.5% Market Closed
Market Cap: 439.6m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

Xeris Biopharma Holdings Inc
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Xeris Biopharma Holdings Inc
Deferred Income Tax Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Deferred Income Tax
$3.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Deferred Income Tax
$2.6B
CAGR 3-Years
-34%
CAGR 5-Years
-19%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Deferred Income Tax
$461m
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
22%
Pfizer Inc
NYSE:PFE
Deferred Income Tax
$2.2B
CAGR 3-Years
-19%
CAGR 5-Years
-7%
CAGR 10-Years
-22%
Merck & Co Inc
NYSE:MRK
Deferred Income Tax
$876m
CAGR 3-Years
-16%
CAGR 5-Years
-16%
CAGR 10-Years
-15%
Eli Lilly and Co
NYSE:LLY
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Xeris Biopharma Holdings Inc's Deferred Income Tax?
Deferred Income Tax
3.3m USD

Based on the financial report for Jun 30, 2024, Xeris Biopharma Holdings Inc's Deferred Income Tax amounts to 3.3m USD.

What is Xeris Biopharma Holdings Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 1Y
19%

Over the last year, the Deferred Income Tax growth was 19%.

Back to Top